ACE Configurator for ELISpot (ACE): Optimizing Combinatorial Design of Pooled ELISpot Assays with an Epitope Similarity Model
Preprint
Abstract
The ELISpot assay is a powerful in vitro immunoassay that enables cost-effective quantification of antigen-specific T-cell reactivity. It is widely used in the context of cancer and infectious diseases to validate the immunogenicity of epitopes. While technological advances in hardware and software have kept pace with the need for increased throughput, assay design and deconvolution methodology have largely remained stagnant. Current methods for designing multiplexed ELISpot assays are restricted to preset configurations, lack support for high-throughput scenarios, and ignore peptide identity during pool assignment. We introduce the ACE Configurator for ELISpot (ACE) to address these gaps. ACE generates optimized peptide-pool assignments from highly customizable user inputs and handles positive peptide deconvolution using assay readouts. We present a novel sequence-aware pooling strategy, powered by a fine-tuned ESM-2 deep sequence model to identify immunologically similar peptides, reducing the number of false positives and subsequent confirmatory assays. To validate the performance of ACE using real-world datasets, we conducted a comprehensive benchmark study against various design heuristics, deconvolution methods, and experimental conditions, contextualizing design parameter choices with their impact on precision and number of total pools. Our results demonstrate ACE’s capacity to further increase precision of identified immunogenic peptides, maximizing experimental efficiency at the bench-side. ACE is freely available as an executable with a graphical user interface and command-line interfaces at https://github.com/pirl-unc/ace .Keywords
All Related Versions
- Published version: Briefings in Bioinformatics, 25 (1).
This publication has 43 references indexed in Scilit:
- WT1-specific T-cell responses in high-risk multiple myeloma patients undergoing allogeneic T cell–depleted hematopoietic stem cell transplantation and donor lymphocyte infusionsBlood, 2013
- Response definition criteria for ELISPOT assays revisitedCancer Immunology, Immunotherapy, 2010
- Immune epitope mapping in the post-genomic era: lessons for vaccine developmentCurrent Opinion in Immunology, 2007
- CD8+ T cells in autoimmunityCurrent Opinion in Immunology, 2005
- Comprehensive Epitope Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses Directed against the Entire Expressed HIV-1 Genome Demonstrate Broadly Directed Responses, but No Correlation to Viral LoadJournal of Virology, 2003
- Quantification of antigen specific CD8+ T cells using an ELISPOT assayJournal of Immunological Methods, 1995
- CD8+ T-cell memory to virusesCurrent Opinion in Immunology, 1994
- High-Resolution Epitope Mapping of hGH-Receptor Interactions by Alanine-Scanning MutagenesisScience, 1989
- Reverse ELISPOT assay for clonal analysis of cytokine production I. Enumeration of gamma-interferon-secreting cellsJournal of Immunological Methods, 1988
- THE TRANSFORMATION OF POISSON, BINOMIAL AND NEGATIVE-BINOMIAL DATABiometrika, 1948